LP266270-0
Delafloxacin
Active
Description
Delafloxacin (DLX), trade name Baxdela, is a fluoroquinolone antibacterial used to treat acute bacterial skin and skin structure infections (ABSSSIs), which include cellulitis and erysipelas, wound infections and major skin abscesses. DLX is active against a broad spectrum of microorganisms, including those resistant to other fluoroquinolones such as MRSA (methicillin-resistant Staphylococcus aureus), a major cause of hospital-acquired skin infections. PMID: 28356714 Source: Regenstrief LOINC
Basic Part Properties
- Part Name
- Delafloxacin
- Part Display Name
- Delafloxacin
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2018-02-23
- Construct for LOINC Short Name
- DLX
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP266270-0
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| it-IT | Italian (Italy) | Delafloxacina |
| zh-CN | Chinese (China) | 德拉沙星 Synonyms: CAS 189279-58-1; |
| es-ES | Spanish (Spain) | Delafloxacina |
| el-GR | Greek (Greece) | Δελαφλοξασίνη Synonyms: Δελαφλοξασίνη |
LOINC Copyright
Copyright © 2025 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://